Bioinformatics and Drug Discovery
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC54211372. GENOMIC SEQUENCE AND EXOME DATA IN DRUG DISCOVERY. One of the early contributions from bioinformatics to drug target discovery is the identification of sequence homology between simian sarcoma virus onc gene, v-sis, and a platelet-derived growth factor (PDGF) by simple string matching [5, 6].This finding not only resulted in PDGF being used as a cancer drug target [7-9], …
Bioinformatics in drug development and assessment
pubmed.ncbi.nlm.nih.gov › 15931766Abstract. Bioinformatics is playing an increasingly important role in nearly all aspects of drug discovery, drug assessment, and drug development. This growing importance lies not only in the role that bioinformatics plays in handling large volumes of data, but also in the utility of bioinformatics tools to predict, analyze, or help interpret clinical and preclinical findings.
Bioinformatics, Genomics, and Proteomics Tools in Drug Design
www.sciforschenonline.org › journals › drugMar 29, 2019 · The evolution of drug design depends on many factors including identification of the increasing number of new drug targets (gene, protein, or receptor), accumulated data obtained from X-ray crystallographic studies revealing the three-dimensional structures of thousands of proteins (PDB database), advances in computing power of bioinformatics, and availability of tools for predicting protein-drug interactions [9].
Bioinformatics and Drug Discovery
www.ncbi.nlm.nih.gov › pmc › articlesThe key objectives of such comparisons are to 1) connect disease symptoms to genetic mutations, epigenetic modifications, and other environmental factors modulating gene expression, 2) identify drug targets that can either restore cellular function or eliminate malfunctioning cells, e.g., cancer cells, 3) predict or refine drug candidates that can act upon the drug target to achieve the designed therapeutic result and minimize side effects, and 4) assess the impact on environmental health ...